For nearly one-third of the 3 million adults in the United States living with epilepsy, medications fail to control seizures.

A double-blind randomized controlled trial published in Epilepsia provides evidence that deep brain stimulation (DBS) of the anterior nucleus of the thalamus can significantly reduce the monthly ...

Argent BioPharma’s flagship cannabinoid-based therapy for refractory epilepsy has been approved for prescription in Germany. ...

CannEpil, a cannabinoid-based therapy for refractory epilepsy, has been approved for prescription in Germany under a special ...

Rapport Therapeutics focuses on developing specific small molecule therapies for CNS diseases. Check out my recommendation ...

We evaluated our clinical experience with zonisamide, a broad-spectrum antiepileptic drug, in a group of children with predominantly medically refractory epilepsy. A retrospective chart review was ...

A real-world study supports cenobamate as an effective option for patients with drug-resistant epilepsy even after multiple ...